Elevating the Site-Sponsor Experience: SaaS-Based Safety Notifications for Clinical Trials



Wednesday, February 16, 2022 at 11am EST Are duplicative and voluminous safety letters from your clinical trials overwhelming investigators and staff? See how the Safety Notifications module of the IQVIA Investigator Site Portal can ease the administrative burden and put the focus back on patient safety in this complimentary webinar from IQVIA Technologies.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/saas_safety

Event overview:

Notifying investigators about serious adverse events that occur during clinical trials is an important requirement that helps protect research participants; however, when the volume of paper and email notifications becomes overwhelming, research sites may lose the clinical relevance of individual events as they struggle to manage acknowledgements and remain compliant.

In this webinar, you’ll learn how IQVIA Technologies (formerly DrugDev) is solving this clinical safety dilemma. The single sign-on, SaaS-based Safety Notifications module of the IQVIA Investigator Site Portal centralizes and simplifies the creation, distribution, and acknowledgement of safety letters for both sites and sponsors. Join us to see how sponsors are eliminating redundancy for their sites across molecules and studies, while gaining complete oversight of the safety notifications process.

3 Key Take-Aways

  • Learn how to eliminate both over-communication and under-communication of safety events to investigators
  • See in action an intuitive safety notifications system that reduces site burden and increases compliance with reporting rules around the globe
  • Understand the value of an integrated data experience that feeds future site selection criteria and enables continuous process improvement


KK Rumrill
Sr. Director, General Manager, Digital Planning and Site Suites
IQVIA Technologies

KK Rumrill has more than 25 years’ experience in product development, customer support, and implementation services teams in clinical trials. She was a key leader in client operations at BBK Worldwide, driving growth in global patient recruitment, site engagement, and trial optimization. In 2013, KK moved to TrialNetworks, which was acquired by DrugDev and subsequently by IQVIA in 2017. She now leads several key product teams in IQVIA Technologies’ Orchestrated Clinical Trials platform.

Jayasri Vaidyanath

Associate Director, Product Management, Safety Notifications and Reporting Strategy
IQVIA Technologies

Jayasri has more than 14 years of professional experience in the IT industry, with a focus on Safety and Clinical products. At IQVIA Technologies, Jayasri is responsible for managing and executing Product Strategy for the Safety Notifications product. This includes collaborating with engineering and delivery teams to provide valuable solutions for customers.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/saas_safety

Related Content
© 2024 MJH Life Sciences

All rights reserved.